share_log
Breakings ·  Nov 14, 2024 20:01
Nuvectis Pharma Inc - Additional Phase 1B Clinical Data Expected in Q2 2025
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment